Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 17, 2021

One Drop obtains CE Mark for AI-based blood glucose predictions

One Drop’s Blood Glucose Prediction Analysis Engine, which can estimate glucose levels of diabetic patients, gets CE Mark.

One Drop has received CE Mark for the Blood Glucose Prediction Analysis Engine to precisely estimate glucose levels for people with prediabetes, as well as type 2 and gestational diabetes.

The company noted that its tool can predict glucose levels up to eight hours in advance.

The latest approval is based on the accuracy and self-reported use of the company’s eight-hour glucose forecasts, One Drop added.

Compared with other digital health solutions, which use machine learning for backend infrastructure, One Drop utilises artificial intelligence (AI) to provide quick insights to users.

The One Drop app users get glucose forecasts and behavioural predictions upon the availability of the latest data on food, physical activity or glucose.

Digital membership users can also utilise the app to get personalised coaching, interactive educational content and health data tracking tools.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

One Drop CEO and founder Jeff Dachis said: “Receiving the CE Mark reflects One Drop’s commitment to quality, safety, and compliance for the benefit of our global community.

“This recognition helps us on our mission to transform health, change lives, and create opportunities. By empowering people living with chronic conditions to finely tune their decisions, One Drop sets them on the path to better health outcomes, peak performance, and a more fulfilling life.”

The app obtains glucose, weight, blood pressure, food, medicines, and physical activity via manual input, connected medical devices such as the One Drop meter and direct combinations with HealthKit, GoogleFit, Dexcom, Fitbit, Apple Watch and Companion Medical.

One Drop noted that 94% of app users who gave survey feedback said that the glucose forecasts and insights were beneficial.

By connecting daily behaviours with outcomes, glucose predictions and insights assist healthy decisions and provide ongoing assistance to supplement the support from the healthcare provider.

As One Drop’s algorithms depend on its data wealth instead of continuous glucose testing, the AI-driven feature can considerably decrease the use of fingerstick glucose checking.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU